Pierre Kemula

CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the Financial Times reported on Thursday. What Happened: Kemula told FT the German vaccine developer is still hopeful the...